Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The University of Queensland (UQ) in Australia has reported positive data from preclinical tests of its Covid-19 vaccine candidate conducted by Viroclinics-DDL in the Netherlands.
Data indicates the candidate’s effectiveness and manufacturability. The vaccine reportedly generated neutralising immune response against Covid-19 in animal models.
In some animals, the candidate provided protection against virus replication and decreased lung inflammation, and generated a strong T-cell response.